Page last updated: 2024-10-23

aspirin and Gastroparesis

aspirin has been researched along with Gastroparesis in 2 studies

Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.

Gastroparesis: Chronic delayed gastric emptying. Gastroparesis may be caused by motor dysfunction or paralysis of STOMACH muscles or may be associated with other systemic diseases such as DIABETES MELLITUS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cerit, L1
Duygu, H1
Bhatt, DL1
Grosser, T1
Dong, JF1
Logan, D1
Jeske, W1
Angiolillo, DJ1
Frelinger, AL1
Liang, J1
Cryer, B1
Marathi, U1

Other Studies

2 other studies available for aspirin and Gastroparesis

ArticleYear
Collapse of the Aspirin Empire: Is it Diabetic Gastroparesis or Cardioprotective Paresis?
    Journal of the American College of Cardiology, 2017, 06-13, Volume: 69, Issue:23

    Topics: Aspirin; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Gastroparesis; Humans; Paresis

2017
Reply: Collapse of the Aspirin Empire: Is it Diabetic Gastroparesis or Cardioprotective Paresis?
    Journal of the American College of Cardiology, 2017, 06-13, Volume: 69, Issue:23

    Topics: Aspirin; Diabetic Neuropathies; Gastroparesis; Humans; Paresis

2017